Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

Clinical trial NCT01419717 · COMPLETED

Trial details

NCT number: NCT01419717
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bone Metastases in Men With Hormone-Refractory Prostate Cancer Bone Metastases in Subjects With Advanced Breast Cancer

Start date: 2011-11-22
Primary completion: 2018-08-10
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.